A Call for the Digital/Social Expert [Consultant] as a Priority Partner

With nearly a decade working in the rapidly evolving industry, I’ve noticed a variety of reasons why the pitch process, relationships between digital/social experts, account teams at agencies and properly following through on execution are not working smoothly. This is one of the core reasons behind Pharma’s lack of progress – not to minimize regulatory hurdles at all – but we also need to recognize that traditional PR, advertising, marketing processes and people are being deployed into what is a very complex, dynamic environment.

Pharma, We Already Have Our FDA Social Media Guidelines

Still waiting for the FDA to tell Pharma what we can do in Social Media? Folks, we already have our guidelines. Reading an old article last night (note: from Jan 2014) made me realize some of the real reasons behind Pharma’s struggle with social media – and it’s not because of the FDA or lack of guidance. While the…

Pharma Mobile Apps Are Not Dead and Kudos Sanofi, But More Can Be Done

In my eyes, we’ve only uncovered the tip of the iceberg for health and mobile, it has always just been a matter of avoiding the giant block of ambiguous ice that lives underneath that tip – but with the proper navigation, the opportunity for innovation and success is unlimited. The caution comes mostly in the fear of risk (with…

Mobile Apps & Search to Enhance Doctor-Patient Discussions

Search and the fact that a mobile device may already be in a physician’s hand during a patient visit offers a unique opportunity – let’s use that device to better communicate information about a disease or condition to the patient in a way they are more likely to understand. Technology allows touch interaction, video provides a visual means of understanding. Memorability even comes merely in the form of awe in how cool an app may be, leading one to explore others like it.

Community Managers: Striking a Balance Between Passion and Experience

The most successful community managers will be passionate about their work, which means the content they’re sharing will be higher quality and the conversations they are having more relevant. Personality, enthusiasm and expertise in the topics shows true commitment, which entices engagement and builds trust within the community – especially as it relates to health.  Community Managers – the…

HEY PHARMA! Time to Embrace Being Social.

Facebook’s recent newsfeed algorithm change has presented an indirect a wake-up call for pharma: it’s time to learn how to be social. It’s more imperative than ever to garner engagement on your posts, so adapt accordingly. But why is it that pharma has struggled to be successful in what may arguably be one of the most…

Explained: New FDA Guidance on Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media

Translation: What aspects of social media is pharma responsible for and the process for interacting in real-time while adhering to FDA postmarketing submission guidelines. On the path to releasing full guidance for pharma promotional activities in social media in July 2014, yesterday, the Food and Drug Administration (FDA) released draft guidance for comment, specific to…

FDA Issues Guidance for Responding to Requests for Off- Label Information Online

Includes use of Digital/Social for this Purpose The FDA quietly issued a 15-page draft guidance on December 28th 2011, outlining how manufacturers could respond to solicited and unsolicited requests for off-label information. The draft addresses both private requests, such as one-on-one communications, and requests made in public forums – such as conferences, product websites, blogs,…